Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestreamed Session
Browse by Presenter
Home
Browse by Presenter
Browse by Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
N
Nageotte, Emily
UH Rainbow Babies & Children's Hospital
RT3.14- Collaboration Between Physical Therapy & Dietitians
Emily Nageotte
Favorite
Naranjo, Diana
Stanford School of Medicine
DG12--Adjusting & Thriving After a CFRD Diagnosis
Diana Naranjo
Favorite
Narkewicz, Michael
University of Colorado SOM and Children's Hospital Colorado
RT02.7- Unraveling the Mystery of Elevated Liver & HEMT: Is This DILI?
Michael Narkewicz
Favorite
S25.1- Liver Injury in CF Patients
Michael Narkewicz
Favorite
Impact of elexacaftor, tezacaftor and ivacaftor on hepatic status after 4-5 years: Results of the combined PROMISE and RECOVER studies.
Michael Narkewicz
Favorite
Nasr, Samya
University of Michigan Health
DG14--Delivering CF Care in Low & Middle Income Countries
Samya Nasr
Favorite
W18.1- Progression of Cystic Fibrosis Care in Egypt
Samya Nasr
Favorite
Nazari, Amirala
University of Saskatchewan
W34.3- Pulmonary ionocytes regulate airway surface liquid pH, viscosity, and mucociliary clearance in the large airway in swine
Amirala Nazari
Favorite
Nelson, Kecia
MU Children's Hospital
FSC05--A Conversation with Kecia Nelson
Kecia Nelson
Favorite
Nevel, Rebekah
University of Missouri
W04.3- Empowering the cystic fibrosis team: Initiating and accelerating quality improvement in a pediatric center
Rebekah Nevel
Favorite
Newby, Gregory
Johns Hopkins University
PPC-- PTAC/CFTR (Not a Session)
Gregory Newby
Favorite
W30--Gene Editing: Delivery of Gene Editors
Gregory Newby
Favorite
Nicholson, Lisa
Case Western Reserve University.
A CFTR mouse model to study nonsense mutations independent of nonsense-mediated decay.
Lisa Nicholson
Favorite
W29.3- Targeted eRF3a degradation amplifies nonsense mutation readthrough in a CF murine model.
Lisa Nicholson
Favorite
Nick, Jerry
National Jewish Health
PPC-- CLIN (Not a Session)
Jerry Nick
Favorite
S27.1- Current status of phage therapy clinical trials
Jerry Nick
Favorite
Noel, Melanie
University of Calgary
SPC01--Morning- Together We Thrive: A Team-based Approach to Address Medical Traumatic Stress in PwCF Across the Lifespan
Melanie Noel
Favorite
SPC02--Afternoon- Healing the Hurt: Managing Pain with Evidence-based Strategies
Melanie Noel
Favorite
Northey, Beth
UW Health Kids
W04.1- Addition of outpatient clinical pharmacy services can reduce nursing time spent on CF medication access challenges
Beth Northey
Favorite
Norton, Lacey
N/A
S12.1- “I Don’t Have CF but My Baby Does”: Experiences of Parents without CF Who Used CFTR Modulators During Pregnancy or Breastfeeding
Lacey Norton
Favorite
Norton, Melissa
S18.1- Pros and Cons of GLP-1 agonists
Melissa Norton
Favorite
Nyquist, Alan
Inova Advanced Lung Disease and Transplant Department
PGR1- Management of Anal Condylomas Before and After Lung Transplant in a Person with Cystic Fibrosis and HIV
Alan Nyquist
Favorite
